Tech Company Financing Transactions
Nanochon Funding Round
Nanochon closed a $4.1 million Seed financing round on 1/12/2026. Investors included cultivate(MD), private investors and University of Virginia Health System.
Transaction Overview
Company Name
Announced On
1/12/2026
Transaction Type
Venture Equity
Amount
$4,100,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to sustain its first in-human clinical study in Canada, ectend research and development efforts, and begin planning for its future pivotal trial.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
7144 13th Place Northwest 2200
Washington, DC 20012
USA
Washington, DC 20012
USA
Phone
Undisclosed
Website
Email Address
Overview
Nanochon's mission is to develop a new approach to treat cartilage replacement and repair so that the hundreds of thousands of young, active patients with knee damage can return to their lifestyles without having to undergo costly and invasive short-term fixes. Founded in 2016, our technology is a minimally-invasive early intervention that could help avert the need for total knee replacement.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Benjamin Holmes
Chief Financial Officer
Matthew Scherer
Chief Technical Officer
Nathan Castro
Browse more venture capital transactions:
Prev: 1/9/2026: BlueNalu venture capital transaction
Next: 1/12/2026: Cast AI venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to record every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs